Glioma is a peer-reviewed english-language open-access journal published by Wolters Kluwer Medknow Publications in India, operating under an open-access model since 2018. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors publish in Glioma without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-SA license (see other journals using this license).
To date, Glioma has published 143 articles. Articles are minted with DOIs through the prefix 10.4103. All submissions undergo plagiarism screening before peer review.
Keywords
biotherapy, chemotherapy, glioma, central nervous system tumours, radiotherapy
At a glance
- Publisher
- Wolters Kluwer Medknow Publications
- Country
- India
- Primary language
- English
- License
- CC BY-NC-SA
- Peer review
- Double anonymous peer review
- OA since
- 2018
- Review time
- 20 weeks
- DOI prefix
10.4103- Plagiarism check
- Yes
ISSN
- 2589-6113
- electronic
- 2589-6121
Frequently asked questions
Is Glioma peer-reviewed?
Does Glioma charge an article processing charge (APC)?
What subjects does Glioma publish?
What languages does Glioma accept?
What is the ISSN of Glioma?
2589-6113 (print) · 2589-6121 (electronic).